Flow cytometry ""Ogata score"" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience (2019)
- Authors:
- Autor USP: VELLOSO, ELVIRA DEOLINDA RODRIGUES PEREIRA - FM
- Unidade: FM
- DOI: 10.1111/ijlh.13047
- Subjects: DOENÇAS DA MEDULA ESPINHAL; CITOMETRIA DE FLUXO; TÉCNICAS DE DIAGNÓSTICO E PROCEDIMENTOS; SENSIBILIDADE E ESPECIFICIDADE
- Language: Inglês
- Imprenta:
- Source:
- Título: International journal of laboratory hematology
- ISSN: 1751-5521
- Volume/Número/Paginação/Ano: v. 41, n. 4, p. 536-541, 2019
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
MONTAUBAN, Sofia Grille et al. Flow cytometry ""Ogata score"" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience. International journal of laboratory hematology, v. 41, n. 4, p. 536-541, 2019Tradução . . Disponível em: https://doi.org/10.1111/ijlh.13047. Acesso em: 06 maio 2026. -
APA
Montauban, S. G., Hernandez-perez, C. R., Velloso, E. D. R. P., Novoa, V., Lorand-metze, I., Gonzalez, J., et al. (2019). Flow cytometry ""Ogata score"" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience. International journal of laboratory hematology, 41( 4), 536-541. doi:10.1111/ijlh.13047 -
NLM
Montauban SG, Hernandez-perez CR, Velloso EDRP, Novoa V, Lorand-metze I, Gonzalez J, Solari L, Cismondi V, Serrano JC, Burgnini A. Flow cytometry ""Ogata score"" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience [Internet]. International journal of laboratory hematology. 2019 ; 41( 4): 536-541.[citado 2026 maio 06 ] Available from: https://doi.org/10.1111/ijlh.13047 -
Vancouver
Montauban SG, Hernandez-perez CR, Velloso EDRP, Novoa V, Lorand-metze I, Gonzalez J, Solari L, Cismondi V, Serrano JC, Burgnini A. Flow cytometry ""Ogata score"" for the diagnosis of myelodysplastic syndromes in a real-life setting. A Latin American experience [Internet]. International journal of laboratory hematology. 2019 ; 41( 4): 536-541.[citado 2026 maio 06 ] Available from: https://doi.org/10.1111/ijlh.13047 - Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. [Carta]
- Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome
- Aids: manifestações hematológicas e oncólogicas relacionadas
- TCRAD rearrangement in B-cell precursor leukemia: an unexpected finding
- Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients
- Part 3: Myelodysplastic syndromes—treatment of low-risk patients without the 5q deletion
- Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
- Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates
- Tratamento onco-hematólogico no idoso - indicações e limitações
- Contribuicao ao estudo clinico e hematologico das sindromes mielodisplasicas
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
